Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
BETA v.3.0

2025 ICD-10-CM code O72.3

Postpartum coagulation defects, including postpartum afibrinogenemia and postpartum fibrinolysis.

Code O72.3 is used for maternal records only and should never appear on the newborn record. Use additional code Z3A.- to specify the week of gestation, if known.

Medical necessity for the treatment of postpartum coagulation defects is established by the presence of excessive bleeding or evidence of a coagulation abnormality that poses a risk to the patient's health.The documentation should support the diagnosis and the need for the specific interventions performed.

The physician is responsible for diagnosing and managing postpartum coagulation defects, which involves assessing bleeding, ordering relevant laboratory tests (e.g., coagulation profile, complete blood count), providing appropriate treatment (e.g., blood product transfusion, uterotonic agents, medications to promote clotting), and monitoring the patient's condition.

In simple words: This code refers to problems with blood clotting after childbirth.

This code describes a condition of abnormal blood clotting that occurs after childbirth. It includes several specific coagulation defects like postpartum afibrinogenemia (low levels of fibrinogen, a protein essential for clotting) and postpartum fibrinolysis (excessive breakdown of blood clots).

Example 1: A patient experiences excessive bleeding after a vaginal delivery.Lab tests reveal low fibrinogen levels, indicating postpartum afibrinogenemia., Following a cesarean section, a patient develops persistent oozing from the surgical site.Tests confirm excessive fibrinolysis as the cause., A woman with a known family history of bleeding disorders experiences heavy bleeding after giving birth. Despite administration of uterotonic medications, the bleeding continues, and she is diagnosed with a postpartum coagulation defect.

Documentation should include: estimated blood loss, vital signs, laboratory results (coagulation studies, complete blood count), medications administered, clinical findings related to bleeding, and response to treatment.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.

Discover what matters.

iFrame™ AI's knowledge is aligned with and limited to the materials uploaded by users and should not be interpreted as medical, legal, or any other form of advice by iFrame™.